HealthInvest Equity Partners (“HealthInvest”) is an investment firm focused on building successful healthcare businesses. Over the past 20 years, the principals of the firm have invested in many successful healthcare services companies at all stages of development, including American Renal Associates (now NYSE: ARA), Ascend Health Corporation (sold to Universal Health Services – NYSE: UHS), Medicus (sold to NORCAL Mutual Insurance Co.), Medmark Services (sold to Webster Capital), Odyssey Healthcare, Inc. (NASDAQ: ODSY, later sold to Gentiva – NASDAQ: GTIV), and Sempercare, Inc. (sold to Select Medical – NYSE: SEM), CareWell Urgent Care Centers of New England (Sold to Private Equity investor), Ambra Health (Sold to Intelerad), Current active healthcare services investments managed by the principals include Genome Medical, and SUN Behavioral Health LLC. In all of these companies, the HealthInvest Equity Partners principals were founding or among the first institutional investors.
The healthcare services expenditures are over $3.0 trillion in the U.S., and are projected to grow at a 5% annual pace this decade. The market consists of many compelling sectors in which to start and grow successful new businesses. We are actively seeking such early-stage investment opportunities.